Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161)

Name: Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161)
Published: 2018
License: Public Domain

Merck Sharp & Dohme LLC · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

advanced melanoma, programmed cell death-1 (pd-1), pd1, programmed cell death-ligand 1 (pd-l1), programmed cell death-ligand 2 (pd-l2), pdl1, pdl2, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161)

Related documents